The Cytomegalovirus protein pUL37×1 targets mitochondria to mediate neuroprotection

Chien Tai Hong1,2,3, Kai-Yin Chau1, Anthony H V Schapira1

  • 1Department of Clinical Neuroscience, UCL Institute of Neurology, University College London, UK.

Scientific Reports
|August 27, 2016
PubMed

Insights

Human cytomegalovirus protein pUL37×1 offers neuroprotection in Parkinson disease models by preventing apoptosis through dual mechanisms. This protein enhances glycolysis and inhibits cell death pathways, suggesting a novel therapeutic strategy.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Virology

Background:

  • Mitochondrial dysfunction is a key factor in Parkinson disease (PD) pathogenesis.
  • This dysfunction involves impaired oxidative phosphorylation, mitophagy, oxidative stress, and apoptosis.
  • Human cytomegalovirus immediate-early protein pUL37×1 interacts with apoptotic pathways.

Purpose of the Study:

  • To investigate the neuroprotective role of human cytomegalovirus immediate-early protein pUL37×1 in neuronal cells.
  • To elucidate the mechanisms by which pUL37×1 confers protection against apoptosis and cell death.

Main Methods:

  • Over-expression of pUL37×1 in neuronal cells.
  • Induction of apoptosis using staurosporine and 6-hydroxydopamine.
  • Assessment of cell death and apoptosis.
  • Bax silencing experiments.
  • Measurement of glycolysis and mitochondrial membrane potential.

Main Results:

  • pUL37×1 over-expression protected neuronal cells against apoptosis and cell death.
  • Protection was mediated by Bax translocation and inactivation, a Bax-dependent mechanism.
  • pUL37×1 also exhibited Bax-independent anti-apoptotic effects by increasing glycolysis and mitochondrial hyperpolarization.
  • Glycolysis was enhanced via calcium-dependent activation of phosphofructokinase.

Conclusions:

  • pUL37×1 possesses a dual anti-apoptotic mechanism, acting through both Bax-dependent and Bax-independent pathways.
  • This protein's ability to modulate mitochondrial function and apoptosis presents a potential neuroprotective strategy.
  • The findings suggest therapeutic implications for diseases involving mitochondrial dysfunction and apoptosis, such as Parkinson disease.

Related Concept Videos

Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
3.9K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.6K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
5.9K